Skip to main content
Jennifer Holter-Chakrabarty, MD, Oncology, Oklahoma City, OK

JenniferLHolter-ChakrabartyMD

Oncology Oklahoma City, OK

Physician

Dr. Holter-Chakrabarty is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Holter-Chakrabarty's full profile

Already have an account?

  • Office

    825 NE 10th St
    Oupb 5200
    Oklahoma City, OK 73104
    Phone+1 405-271-8299

Education & Training

  • University of Oklahoma Health Sciences Center
    University of Oklahoma Health Sciences CenterFellowship, Hematology and Medical Oncology, 2002 - 2005
  • University of Oklahoma Health Sciences Center
    University of Oklahoma Health Sciences CenterResidency, Internal Medicine, 1999 - 2002
  • University of Oklahoma College of Medicine
    University of Oklahoma College of MedicineClass of 1999

Certifications & Licensure

  • OK State Medical License
    OK State Medical License 2000 - 2025
  • American Board of Internal Medicine Hematology

Publications & Presentations

PubMed

Abstracts/Posters

  • Hypomethylating Agent Maintenance Therapy after Allogeneic Stem Cell Transplant Improves Transplant Outcome in High Risk Acute Myelogenous Leukemia
    Jennifer Holter Chakrabarty, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Press Mentions

  • PET Visualizes Acute Graft Versus Host Disease
    PET Visualizes Acute Graft Versus Host DiseaseDecember 16th, 2024
  • PET Visualizes Acute Graft vs. Host Disease
    PET Visualizes Acute Graft vs. Host DiseaseDecember 16th, 2024
  • The Leukemia & Lymphoma Society (LLS) and the American Society of Hematology (ASH) Team up to Connect Blood Cancer Patients to Clinical Trials That Can Lead to New and Better Treatments
    The Leukemia & Lymphoma Society (LLS) and the American Society of Hematology (ASH) Team up to Connect Blood Cancer Patients to Clinical Trials That Can Lead to New and Better TreatmentsDecember 6th, 2019
  • Join now to see all